¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"alpha chain disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • Crouzon¡¯s disease
    Å©·çÁ¾º´
  • Cushing¡¯s disease
    Äí½Ìº´
  • cystic kidney disease
    ³¶¼ºÄáÆÏº´, ³¶¼º½ÅÀ庴
  • cystine disease
    ½Ã½ºÆ¾º´
  • cystine storage disease
    ½Ã½ºÆ¾ÃàÀûº´
  • cytomegalic inclusion disease
    °Å´ë¼¼Æ÷Æ÷ÇÔº´, °Å´ë¼¼Æ÷ºÀÀÔüº´
  • cardiovascular disease
    ½É(Àå)Ç÷°üÁúȯ
  • Caroli disease
    Ä«·Ñ¸®º´
  • cat-scratch disease
    °í¾çÀÌÇÒÅ¡º´
  • celiac disease
    º¹°­º´, º¹°­Áúȯ
  • Center for Disease Control and Prevention
    Áúº´°ü¸®¿¹¹æ¼¾ÅÍ
  • central core disease
    Áß½ÉÇÙº´, Áß½ÉÄھ
  • caloric disease
    °í¿Âº´
  • cerebrovascular disease
    ³úÇ÷°üÁúȯ, ³úÇ÷°üº´
  • Charcot-Marie-Tooth disease
    »þ¸£ÄÚ-¸¶¸®-Åõ½ºº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • cystine disease
    ½Ã½ºÆ¾º´
  • cystine storage disease
    ½Ã½ºÆ¾ÃàÀûº´
  • cytomegalic inclusion disease
    ¼¼Æ÷°Å´ëÆ÷ÇÔº´
  • disease control
    Áúº´°ü¸®
  • venereal disease control
    ¼ºº´°ü¸®
  • disease
    º´
  • deficiency disease
    ¿µ¾ç°áÇ̺´
  • degenerative disease
    ÅðÇິ
  • degenerative joint disease
    (¢¡osteoarthritis) »À°üÀý¿°, °ñ°üÀý¿°
  • demyelinating disease
    ¸»ÀÌÁýÅ»¶ôº´
  • dense deposit disease
    °í¹ÐµµÄ§Âøº´
  • depression spectrum disease
    ¿ì¿ï½ºÆåÆ®·³º´
  • detergent worker¡¯s disease
    ¼¼Á¤Á¦Ãë±ÞÀÚº´
  • developmental disease
    ¹ß´ÞÀå¾Ö
  • diarrheal disease
    ¼³»çº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • Cavares disease
    Ä«¹Ù·¹º´ ¡ì°¡Á·¼º Áֱ⼺ ¸¶ºñ¡í.
  • Chagas-disease =Brazilian trypano somia sis
    »þ°¡½ºº´ ¡ì¾Æ¸Þ¸®Ä«Æ®¸®ÆÄ ³ë¼Ò¸¶Áõ¡í.
  • Charcot-Guinon disease
    ¼£Äà ±â³í º´
  • Charcot-Marie-Tooth disease
    »þ¸£ÄÚ-¸¶¸®-Åõ½ºº´.
  • Charcots disease
    »þ¸£ÄÚ º´(¡­Ü»).
  • Charlouis-disease
    »þ¸¦·çÀ̺´.
  • Chesters disease
    ü½ºÅͺ´.
  • Chiari-Frommel disease
    Ű¾Æ¸®ÇÁ·Ò¸áº´.
  • Chicago disease
    ½ÃÄ«°íº´.
  • Christmas disease
    Å©¸®½º¸¶½ºº´
  • Christmas disease
    Å©¸®½º¸¶½º º´
  • Christmas disease=hemophilia B
    Å©¸®½º¸¶½ºº´=Ç÷¿ìº´ B
  • Clostridial disease
    Ŭ·Î½ºÆ®¸®µð¿òº´
  • Coats disease
    ÄÚ¿ìÃ÷º´
  • Coats disease
    ÄÚ¿ìÃ÷º´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • delta (¥ä) chain
    ÅÚŸ»ç½½, µ¨Å¸¼â
  • epsilon (¥å) chain
    ¿¦½Ç·Ð»ç½½, ¿¦½Ç·Ð¼â
  • food chain =biological concentration
    ½Äǰ¿¬¼â(¡­ææáð).
  • gamma (¥ã) chain
    °¨¸¶»ç½½, °¨¸¶¼â
  • heavy chain
    Áß¼â
  • heavy chain
    H¼â(¡­áð), Á߻罽.
  • heavy chain
    Áß¼â, Á߻罽, H¼â
  • hemoglobin a,b-globin chain of
    ¥â-±Û·Îºó¼â(¡­áð)
  • hemolytic chain
    ¿ëÇ÷¿¬¼â.
  • joining chain
    J¼â, J»ç½½
  • kappa (¥ê) chain
    Ä«ÆÄ»ç½½, Ä«ÆÄ¼â
  • lambda (¥ë) chain
    ¶÷´Ù»ç½½, ¶÷´Ù¼â
  • lateral chain
    Ãø¼â(ö°áð).
  • light chain
    °æ¼â
  • light chain
    °æ¼â(Ìîáð).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • open chain
    ¿­¸° »ç½½
  • parallel chain
    ÆòÇà(øÁú¼) »ç½½
  • P-K chain
    P-K »ç½½
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ(ñìùêý£áÈÖ§áðÚãëë)
  • Porod-Kratky chain
    Æ÷·Îµå-Å©¶óŰ »ç½½
  • random flight chain
    ¹«ÀÛÁ¤ ¿¬°á(ÙííÂïÒÖ§Ì¿) »ç½½
  • random walk chain
    ¹«ÀÛÁ¤ ¿¬°á(ÙííÂïÒÖ§Ì¿) »ç½½
  • respiratory chain
    È£Èí ¿¬¼â(Ö§áð)
  • respiratory chain phosphorylation
    È£Èí¿¬¼â ÀλêÈ­(×òß«ûù)
  • side chain
    °ç°¡Áö
  • side chain cleavage
    °ç°¡Áö Àý´Ü(ï·Ó¨)
  • side chain theory
    °ç°¡Áö ÀÌ·Ð(×âÖå)
  • straight chain
    °ðÀº »ç½½
  • triple-chain length
    »ï(ß²)»ç½½ ±æÀÌ
  • two-genes-one-polypeptide chain
    ÀÌÀ¯ÀüÀÚ(ì£ë¶îîí­)- ÀÏ(ìé)Æú¸®ÆéŸÀÌµå »ç½½
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
AID acquired immunodeficiency disease; acute infectious disease; acute ionization detector; Agency for I...
BD barbital-dependent; barbiturate dependence; base deficit; base of prism down; basophilic degeneratio...
CAD cadaver, cadaveric; cold agglutinin disease; compressed air disease; computer-assisted design; compu...
CSD carotid sinus denervation; cat scratch disease; combined system disease; conditionally streptomycin ...
CVD cardiovascular disease; cerebrovascular disease; collagen vascular disease; color-vision-deviant
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
PGF1 alpha 6-keto-prostaglandin 1 alpha
8-epi-PGF2 alpha 8-Epi-prostaglandin F2 alpha
8-iso-PGF(2 alpha) 8-Iso-prostaglandin F(2 alpha
alpha-FP ALPHA-Fetoprotein
alpha 1-AT Alpha 1 antitrypsin
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Christmas disease
    Å©¸®½º¸¶½º Áúȯ
    ÀÌ Áúȯ¿¡ °üÇØ¼­ ÃÖÃÊ·Î »ó¼¼È÷ ¿¬±¸µÈ ȯÀÚÀÇ À̸§¿¡¼­ À¯·¡.
  • chronic disease
    ¸¸¼º Áúȯ
    º´ÀÇ °æ°úÀÇ Àå´Ü¿¡ ÀÇÇÑ ºÐ·ù. º¸Åë 6°³¿ù ȤÀº l³â ÀÌ»ó °è¼ÓµÇ´Â ÁúȯÀ» ¸»Çϸç, ±Þ¼º Áúȯ°ú ´ëÀÀÇÑ´Ù. ±× Áõ¼¼°¡ ¿Ï¸¸ÇÏ°Ô ³ªÅ¸³ª Àå±â°£ Áö¼ÓÇϹǷΠ¸¸¼º Áõ»óÀ̶ó Çϸç, À̰͵µ ±Þ¼º Áúȯ¿¡¼­ÀÇ ±Þ¼º Áõ»ó¿¡ ´ëÀÀÇÏ´Â ¸»ÀÌ´Ù. ´ëÇ¥ÀûÀÎ ¸¸¼º ÁúÇÑÀ¸·Î´Â °áÇÙ, ³ªº´, ¸Åµ¶ µîÀÌ ÀÖ°í, ±Þ¼º Áúȯ¿¡¼­ ÀÌÇàÇÏ´Â °Íµµ ¸¹´Ù. ´Ü¼øÈ÷ ¾ËÄÚ¿Ã Áßµ¶À̳ª °üÀý ·ù¸ÓƼÁò µîÀÇ °æ¿ì´Â ¸¸¼ºÀ¸·Î º¸´Â °æ¿ì°¡ ¸¹´Ù.
  • coeliac disease
    º¹°­ Áúȯ
  • cold hemagglutinin disease
    ÇÑ·© Ç÷ÀÀÁý¼Òº´
  • collagen disease
    ±³¿ø Áúȯ, ±³¿øÁú Áúȯ, ±³¿øº´, ±³¿øÁúº´
    µ¿ÀǾî=connective tissue disorders. º´¸®Á¶Á÷ÇÐÀûÀ¸·Î Ç÷°üÀÇ °áÇÕ Á¶Á÷¿¡ ÆØÈ­³ª ±«»ç µûÀ§ÀÇ º¯È­°¡ ¹ß°ßµÇ´Â ¸ðµç ÁúȯÀ» ÀϰýÇÏ¿©, ±×µéÀÇ »óÈ£°ü·ÃÀ» º¸±â À§ÇØ 1942³â ¹Ì±¹ÀÇ O. Ŭ·½Æä·¯ µî¿¡ ÀÇÇØ¼­ Á¦ÃâµÈ Áý¾à °³³ä.
  • collagen-vascular disease
    ±³¿øÁú-Ç÷°ü¼º Áúȯ
  • combined immunodeficiency disease
    º¹ÇÕÇü ¸é¿ª °áÇÌ Áúȯ
  • combined system disease
    º¹ÇÕ °èÅë Áúȯ
  • combined valvular disease
    º¹ÇÕ ÆÇ¸· Áúȯ
  • connective tissue disease
    °áÇÕÁ¶Á÷ º´, °áÇÕÁ¶Á÷ Áúȯ
  • consumption disease
    ¼Ò¸ð¼º Áúȯ
    ü·ÂÀÇ ¼Ò¸ð. Àü¿¡´Â Æó °áÇÙ¿¡ ´ëÇÏ¿© »ç¿ëµÇ¾ú´Ù.
  • Creutzfeldt-Jakob disease
    ¾ß°ö º´
    ÁßÃ߽Űæ°è¸¦ ħ¹üÇÏ´Â ¹ÙÀÌ·¯½º¼º °¨¿° Áúȯ. Ä¡¸Å°¡ ¿À°Ô µÇ°í °£´ë¼º °æ·ÃÀ» º¸ÀÌ´Ù°¡ »ç¸ÁÇÏ°Ô µÇ´Â °£¿°¼º ÁúȯÀÌ´Ù. Àü¼¼°èÀûÀ¸·Î ºÐÆ÷µÇ¾î ÀÖÀ¸¸ç, Å©·ÎÀÌÃ÷ÆçÆ®-¾ß°ö º´À̶ó°íµµ ÇÑ´Ù. Àü¿° °æ·Î´Â È®½ÇÇÏ°Ô ¾Ë·ÁÁ® ÀÖÁö ¾ÊÀ¸³ª, 1996³â ¿µ±¹¿¡¼­ ¹ßº´ÇÑ ±¤¿ìº´
  • Crohn's disease
    Crohn Áúȯ, Å©·Ð¾¾ º´, Å©·Ð º´
    Å©·ÐÀÌ 1932³â óÀ½À¸·Î ȸÀå ¸»´ÜÀÇ Àå¿°À» ±¹ÇÑÀû ȸÀå¿°À¸·Î ±âÀçÇÑ °Í. ȸÀå ¸»´Ü¿°. ¼ÒÀå, ´ëÀå¿¡¼­µµ º¼ ¼ö ÀÖÀ¸¸ç ȸÀå ¸»´ÜºÎÀÇ °ÅÀÇ 30cm¿¡ ÀÚÁÖ ¹ß»ýÇϰí Á¡¸·¿¡¼­ Á¡¸· ÇÏÃþ¿¡ ¹ÌÄ¡´Â ¿°Áõ¼º º¯È­·Î À°¾Æ °Å´ë¼¼Æ÷¸¦ º¼ ¼ö ÀÖ´Ù. ¿øÀÎÀº Àå³» ¼¼±Õ, ¾Ë·¯Áö µîÀÇ ¿¬°üµÈ °ÍÀ¸·Î º¸ÀδÙ.
  • cyanotic heart disease
    û»ö¼º ½ÉÀå Áúȯ
  • cytomegalic inclusion disease
    ¼¼Æ÷ °Å´ë¼º ºÀÀÔü º´, °Å´ë ¼¼Æ÷ ºÀÀÔü Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
alpha-1,3-mannosylglycoprotein beta-1,4-N-acetylglucosaminyltransferase <enzyme> Incorporates n-acetyglucosamine as the third branch of complex n-glycosyl-oligosaccharide of hen oviduct
Registry number: EC 2.4.1.145
Synonym: glcnac-transferase iv, n-acetylglucosaminyltransferase iv, udp-glcnac-gngn(glcnac to man alpha1-3)beta 4-n-acetylglucosaminyltransferase iv
(26 Jun 1999)
alpha-1,4-glucan lyase <enzyme> Degrades alpha-1,4-glucan to produce 1,5-anhydrofructose; from seaweeds gracilariopsis lemaneiformis and gracilaria verrucosa; mw 111 kD; amino acid sequence has been determined
Registry number: EC 4.2.2.-
Synonym: alpha-1,4-glucan 4-lyase
(26 Jun 1999)
alpha 1-4-mannosyltransferase <enzyme> From mycobacterium smegmatis; involved in methylmannose polysaccharide elongation; GDP-mannose is donor
Registry number: EC 2.4.1.-
(26 Jun 1999)
alpha(1-6)mannosidase <enzyme> Human lysosomal enzyme highly specific for alpha 1-6 mannose residues; inhibited by swainsonine; not the same enzyme which is deficient in alpha-mannosidosis
Registry number: EC 3.2.1.-
(26 Jun 1999)
alpha 1,6-mannosyltransferase <enzyme> From saccharomyces cerevisiae; adds mannose residues in an alpha-1,6-linkage to man8glcnac and man9glcnac in the biosynthesis of the outer chain of yeast mannoproteins
Registry number: EC 2.4.1.-
(26 Jun 1999)
alpha-1 antichymotrypsin <chemical> Glycoprotein found in alpha(1)-globulin region in human serum. It is an inhibiter of the digestive protease, chymotrypsin and other chymotrypsin-like proteinases in vivo and has cytotoxic killer-cell activity in vitro.
The protein also has a role as an acute-phase protein and is active in the control of immunologic and inflammatory processes, and as a tumour marker. It is a member of the serpin superfamily.
Pharmacological action: serine proteinase inhibitors.
(12 Dec 1998)
alpha-1 antitrypsin <chemical> Plasma glycoprotein member of the serpin superfamily which inhibits trypsin, neutrophil elastase, and other proteolytic enzymes. Commonly referred to as alpha 1-proteinase inhibitor (a1pi), it exists in over 30 different biochemical variant forms known collectively as the pi (protease inhibitor) system.
Hereditary deficiency is associated with pulmonary emphysema.
See: alpha-1 antitrypsin deficiency
Pharmacological action: serine proteinase inhibitors, trypsin inhibitors.
(12 Dec 1998)
alpha-1 antitrypsin deficiency <chest medicine> Deficiency of the protease inhibitor alpha-1 antitrypsin, leads primarily to degradation of elastin of the alveolar walls, as well as other structural proteins of a variety of tissues.
The lack of this protein leads to damage of various organs, but mainly to the lung and liver.
symptoms may become apparent at a very early age or in adulthood, manifesting either as shortness of breath or liver related symptoms (jaundice, fatigue, fluid in the abdomen, mental changes, or gastrointestinal bleeding). There are several options for treatment of the lung disease, including replacement of the missing protein. Treatment of the liver disease is a well-timed liver transplant
(12 Dec 1998)
alpha-1-proteinase deficiency Absence of a serum proteinase inhibitor that may cause nodular non-suppurative panniculitis.
(05 Mar 2000)
alpha(2,8)-sialyltransferase <enzyme> Active towards gm1b, gd1a, gt1b, and gd3 gangliosides; genbank u91641
Registry number: EC 3.4.99.-
Synonym: st8sia v, hst8sia v
(26 Jun 1999)
alpha-(4-O-methyl)-D-glucuronidase <enzyme> Removes 4-o-methyl-glucopyranosyl uronic acid residues from the 2-position of fungal cell wall xylans
Registry number: EC 3.2.1.-
Synonym: 4-o-methyl-glucuronidase
(26 Jun 1999)
alpha-acetolactic acid An intermediate in pyruvic acid catabolism and valine biosynthesis; CH3COC(OH)(CH3)-COOH.
(05 Mar 2000)
alpha-actinin An F-actin binding protein in vertebrate cells that cross-links actin filaments into regular parallel arrays.
(05 Mar 2000)
alpha-adrenergic blocking agent An agent that competitively blocks alpha-adrenergic receptors; used in the treatment of hypertension.
Synonym: alpha-blocker.
(05 Mar 2000)
alpha-adrenergic receptors Adrenergic receptor's in effector tissues capable of selective activation and blockade by drugs; conceptually derived from the ability of certain agents, such as phenoxybenzamine, to block only some adrenergic receptor's and of other agents, such as methoxamine, to activate only the same adrenergic receptor's. Such receptor's are designated as alpha-receptors. Their activation results in physiological responses such as increased peripheral vascular resistance, mydriasis, and contraction of pilomotor muscles.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á